Company logo

THW - Tekla World Healthcare Fund

NYSE -> Financial Services -> Asset Management
Boston, United States
Type: Equity

THW price evolution
THW
(in millions $) 30 Oct 2023 1 May 2023 30 Oct 2022 1 May 2022
Current assets
Cash $0 $0 $0 $0
Short term investments
Net receivables $2.62 $2.96 $3.09 $5.68
Inventory
Total current assets $2.95 $3.33 $3.34 $5.78
Long term investments
Property, plant & equipment
Goodwill & intangible assets
Total noncurrent assets
Total investments
Total assets $569.74 $607.18 $582.93 $679.5
Current liabilities
Accounts payable
Deferred revenue
Short long term debt
Total current liabilities $2.4 $7.11 $7.31 $4.96
Long term debt $120 $120 $120 $120
Total noncurrent liabilities
Total debt
Total liabilities $122.62 $127.56 $128.59 $127.41
Shareholders' equity
Retained earnings -$56.72 -$44.64 -$63.93 $14.5
Other shareholder equity
Total shareholder equity
(in millions $) 30 Oct 2023 30 Oct 2022 30 Oct 2021 30 Oct 2020
Current assets
Cash $0 $0 $0 $1.4
Short term investments
Net receivables $2.62 $3.09 $2.76 $2.5
Inventory
Total current assets $2.95 $3.34 $2.81 $3.9
Long term investments
Property, plant & equipment
Goodwill & intangible assets
Total noncurrent assets
Total investments
Total assets $569.74 $582.93 $714.18 $548.1
Current liabilities
Accounts payable $22.18
Deferred revenue
Short long term debt
Total current liabilities $2.4 $7.31 $27.83 $0.8
Long term debt $120 $120 $120 $120
Total noncurrent liabilities
Total debt
Total liabilities $122.62 $128.59 $148.5 $121.6
Shareholders' equity
Retained earnings -$56.72 -$63.93 $29.97 -$50.5
Other shareholder equity
Total shareholder equity
(in millions $) 30 Oct 2023 1 May 2023 30 Oct 2022 1 May 2022
Revenue
Total revenue $5.96 $6.81 $5.68 $6.43
Cost of revenue
Gross Profit -$1.22 $0.41 $0.74 $2.11
Operating activities
Research & development
Selling, general & administrative
Total operating expenses $0.39 $0.42 $0.5 $0.41
Operating income
Income from continuing operations
EBIT
Income tax expense
Interest expense -$6.44 $45.67 -$73.73 $8.94
Net income
Net income -$8.05 $45.67 -$73.48 $10.65
Income (for common shares)
(in millions $) 30 Oct 2023 30 Oct 2022 30 Oct 2021 30 Oct 2020
Revenue
Total revenue $12.78 $12.11 $11.49 $12.12
Cost of revenue
Gross Profit -$0.8 $2.85 $3.41 $3.59
Operating activities
Research & development
Selling, general & administrative
Total operating expenses $0.81 $0.91 $0.74 $0.67
Operating income
Income from continuing operations
EBIT
Income tax expense
Interest expense $39.23 -$64.78 $82.46 $57.98
Net income
Net income $37.62 -$62.84 $85.13 $60.9
Income (for common shares)
(in millions $) 1 May 2023 30 Oct 2022 1 May 2022 30 Oct 2021
Net income
Operating activities
Depreciation
Business acquisitions & disposals
Stock-based compensation
Total cash flows from operations
Investing activities
Capital expenditures
Investments
Total cash flows from investing
Financing activities
Dividends paid -$24.33 -$48.5 -$24.24 -$44.82
Sale and purchase of stock
Net borrowings
Total cash flows from financing -$20.39 -$48.5 -$24.24 $54.01
Effect of exchange rate
Change in cash and equivalents $0.01 -$0.04 -$0.03 -$1.33
(in millions $) 30 Oct 2023 30 Oct 2022 30 Oct 2021 30 Oct 2020
Net income
Operating activities
Depreciation
Business acquisitions & disposals
Stock-based compensation
Total cash flows from operations
Investing activities
Capital expenditures
Investments
Total cash flows from investing
Financing activities
Dividends paid -$48.79 -$48.5 -$44.82 -$41.43
Sale and purchase of stock
Net borrowings
Total cash flows from financing -$44.84 -$48.5 $54.01 -$42.01
Effect of exchange rate
Change in cash and equivalents $0 -$0.04 -$1.33 -$3.83
Fundamentals
Market cap $503.10M
Enterprise value N/A
Shares outstanding 38.11M
Revenue $24.89M
EBITDA N/A
EBIT N/A
Net Income -$25.21M
Revenue Q/Q 5.17%
Revenue Y/Y 5.36%
P/E ratio -19.95
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio 20.22
P/B ratio N/A
Book/Share N/A
Cash/Share 0.00
EPS -$0.66
ROA -4.13%
ROE N/A
Debt/Equity N/A
Net debt/EBITDA N/A
Current ratio 1.23
Quick ratio N/A